Assessing the Burden of Atopic Dermatitis in Portugal through Patient-Centered Experiences

Authors

DOI:

https://doi.org/10.20344/amp.21248

Keywords:

Cost of Illness, Decision Making, Shared, Dermatitis, Atopic/epidemiology, Dermatitis, Atopic/therapy, Patient Education, Portugal, Quality of Life

Abstract

Introduction: Adult patients and caregivers of children with atopic dermatitis experience high physical, mental, and financial burden in Portugal. We outline the experience of atopic dermatitis management and how the current medical care model impacts patient-centered concerns such as financial burden, quality of life, disease burden, and treatment satisfaction.
Methods: We conducted a survey of 419 Portuguese adults and caregivers of children to capture the experience of managing atopic dermatitis in Portugal.
Results: Respondents reported average satisfaction with treatment, with a mean satisfaction rating of 3.15/5.00 (SD = 0.77). Adults reported slightly better control of atopic dermatitis symptoms (mean = 56.6) than pediatric patients (mean = 55.9, caregiver reported). Nearly 34% of adults and 39% of caregivers of children and adolescents indicated that their healthcare providers asked about their priorities at the last medical visit. Additionally, only 40% of adult patients and 32% of caregivers reported that patient training was offered to them. Respondents seeing dermatologists reported higher satisfaction than those seeing other healthcare providers (p = 0.01) but there were no differences in long-term control of symptoms by provider type (p = 0.85) when controlling for severity. Portuguese adult patients scored 0.86/1.00 on the EQ-5D (where 0 = death and 1 = perfect health). Financial concern was high as nearly 80% of patients and caregivers reported using savings, borrowing money, and/or reducing spending to cover atopic dermatitis-related costs.
Conclusion: Portuguese patients with atopic dermatitis and caregivers experience financial burden, lower health-related quality of life, higher disease burden, and treatment satisfaction issues with their current medical care. These factors often deteriorate as the disease’s severity increases. Providers, researchers and policymakers should focus on better addressing patient-centered concerns for individuals suffering from atopic dermatitis to improve care and health outcomes.

Downloads

Download data is not yet available.

References

Barbarot S, Auziere S, Gadkari A, Girolomoni G, Puig L, Simpson D, et al. Epidemiology of atopic dermatitis in adults: results from an international survey. Allergy. 2018;73:1284-93.

Coelho P, Alpalhão M, Victorino G, Camilo J, Cardoso C, Maia Silva J. Understanding the impact of atopic dermatitis in Portuguese patients: results from an analytical observational study. Value Health. 2022;25:S232.

Carvalho D, Aguiar P, Mendes-Bastos P, Palma-Carlos A, Freitas J, Ferrinho P. Quality of life and characterization of patients with atopic dermatitis in Portugal: the QUADEP study. J Investig Allergol Clin Immunol. 2020;30:430-8.

Capozza K, Funk M, Hering M, Lang J, Merhand S, Manion R, et al. Patients’ and caregivers’ experiences with atopic dermatitis-related burden, medical care, and treatments in 8 countries. J Allergy Clin Immunol Pract. 2023;11:264-73.

Torres T, Gonçalo M, Paiva-Lopes M, Claro C, Varela P, Silva J, et al. Atopic dermatitis: improving patient access to health care in dermatology. Port J Dermatol and Venereol. 2023;81:1-8.

Carvalho D, Aguiar P, Ferrinho P, Mendes-Bastos P, Palma-Carlos A. Eczema and urticaria in the adult population in Portugal: a prevalence study. Actas Dermosifiliogr. 2019;110:744-51.

Eyerich K, Gooderham M, Silvestre J, Shumack S, Mendes-Bastos P, Aoki V, et al. Real-world clinical, psychosocial and economic burden of atopic dermatitis: results from a multicountry study. J Eur Acad Dermatol Venereol. 2023;00:1-14.

Pariser D, Simpson E, Gadkari A, Bieber T, Margolis D, Brown M, et al. Evaluating patient-perceived control of atopic dermatitis: design, validation, and scoring of the Atopic Dermatitis Control Tool (ADCT). Curr Med Res Opin. 2019;36:367-76.

EuroQol Group. EuroQol-a new facility for the measurement of healthrelated quality of life. Health Policy. 1990;16:199-208.

Ferreira L, Ferreira P, Pereira L, Oppe M. EQ-5D Portuguese population norms. Qual Life Res. 2014;23:425-30.

Torres T, Gonçalo M, Paiva-Lopes M, Claro C, Ramos L, Selores M, et al. Portuguese recommendations for the treatment of atopic dermatitis with biologic therapy and JAK inhibitors in adult patients. Drugs Context. 2021;10:2021-9-5.

Hartono SP, Chatrath S, Aktas ON, Kubala SA, Capozza K, Myles IA, et al. Interventions for anxiety and depression in patients with atopic dermatitis: a systematic review and meta-analysis. Sci Rep. 2024;14:8844.

Downloads

Published

2024-10-01

How to Cite

1.
Tu M, Moxham F, Schwartz A, Camilo J, Capozza K. Assessing the Burden of Atopic Dermatitis in Portugal through Patient-Centered Experiences. Acta Med Port [Internet]. 2024 Oct. 1 [cited 2024 Nov. 9];37(10):706-12. Available from: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/21248

Issue

Section

Original